Division 2 DEFINITIONSF1F2 United Kingdom Original text. Later amendments are not shown. For the purposes of this Annex, in addition to the definitions laid down in Regulation (EC) No 1394/2007, the definitions set out in sections 2.1 and 2.2 shall apply. 2.1Gene therapy medicinal product 2.2Somatic cell therapy medicinal product Annotations Textual amendments F1 Substituted by Commission directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance). F2 Substituted by Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products (Text with EEA relevance). ← Division 1 Division 2 Division 2.1 →